FNCH: Finch Therapeutics Group, Inc. Stock

by  •  • Comments Off on FNCH: Finch Therapeutics Group, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3.66
Enterprise Value ($M) -21.46
Book Value ($M) 22.89
Book Value / Share 14.25
Price / Book 0.16
NCAV ($M) -6.64
NCAV / Share -4.14
Price / NCAV -0.55

Profitability (mra)
Return on Invested Capital (ROIC) -1.41
Return on Assets (ROA) -0.95
Return on Equity (ROE) -2.27

Liquidity (mrq)
Quick Ratio 6.33
Current Ratio 6.33

Balance Sheet (mrq) ($M)
Current Assets 25.85
Assets 55.37
Liabilities 32.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.11
Operating Income -34.00
Net Income -74.75

Cash Flow Statement (mra) ($M)
Cash From Operations -31.50
Cash from Investing 1.33
Cash from Financing -16.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-13 13G Ugwumba Chidozie 9.99 -95.42

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-29 793 38,758 2.05
2024-04-26 13,639 5,093 267.80
2024-04-25 10,595 7,815 135.57
2024-04-24 27,195 12,254 221.93

(click for more detail)

Similar Companies
EXEL – Exelixis, Inc. FDMT – 4D Molecular Therapeutics, Inc.
FGEN – FibroGen, Inc. FUSN – Fusion Pharmaceuticals Inc.
GBIO – Generation Bio Co.


Financial data and stock pages provided by
Fintel.io